CP
BSX icon

CenterBook Partners’s Boston Scientific BSX Stock Holding History

CenterBook Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,725
Closed -$2.36M – 661
2025
Q4 		$2.36M Sell
24,725
-776
-3% -$76.1K 0.12% 236
2025
Q3 		$2.49M Buy
25,501
+5,708
+29% +$591K 0.12% 223
2025
Q2 		$2.13M Sell
19,793
-6,998
-26% -$708K 0.12% 210
2025
Q1 		$2.7M Buy
26,791
+13,979
+109% +$1.41M 0.17% 155
2024
Q4 		$1.14M Buy
+12,812
New +$1.13M 0.07% 314
2022
Q3 		– Sell
-9,821
Closed -$366K – 395
2022
Q2 		$366K Buy
9,821
+1,837
+23% +$74.8K 0.08% 307
2022
Q1 		$354K Buy
7,984
+2,009
+34% +$87.1K 0.13% 261
2021
Q4 		$254K Buy
+5,975
New +$251K 0.15% 228

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CenterBook Partners's BSX Position: Q1 2026 in Review

CenterBook Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 24,725 shares — an estimated $2.36M sold.

CenterBook Partners first reported a position in BSX in Q4 2021 and held it in 8 quarters. The position peaked at $2.7M in Q1 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • CenterBook Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • CenterBook Partners sold 24,725 Boston Scientific shares in Q1 2026, an estimated $2.36M.
  • CenterBook Partners first reported a position in Boston Scientific in Q4 2021 and held it in 8 quarters.
  • CenterBook Partners's Boston Scientific position peaked at $2.7M in Q1 2025.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.